WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001035987) AN AQUEOUS SOLUTION FORMULATION OF ALPHA-INTERFERON
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/035987    International Application No.:    PCT/KR2000/001322
Publication Date: 25.05.2001 International Filing Date: 17.11.2000
Chapter 2 Demand Filed:    12.06.2001    
IPC:
A61K 47/26 (2006.01)
Applicants: LG CHEM INVESTMENT, LTD. [KR/KR]; 20, Yoido-dong, Youngdungpo-ku, Seoul 150-721 (KR) (For All Designated States Except US).
KANG, Young, Cheol [KR/KR]; (KR) (For US Only).
LEE, Sang-Heon [KR/KR]; (KR) (For US Only).
HAN, Kyuboem [KR/KR]; (KR) (For US Only)
Inventors: KANG, Young, Cheol; (KR).
LEE, Sang-Heon; (KR).
HAN, Kyuboem; (KR)
Agent: CHO, In Jae; 7th Floor, HanJoongAng Building, #646-7, Yoksam-dong, Kangnam-ku, Seoul 135-080 (KR)
Priority Data:
1999/51481 19.11.1999 KR
Title (EN) AN AQUEOUS SOLUTION FORMULATION OF ALPHA-INTERFERON
(FR) FORMULATION D'UNE SOLUTION AQUEUSE DE L'INTERFERON ALPHA
Abstract: front page image
(EN)The present invention relates to an aqueous solution formulation which can retain the biological activity and physicochemical properties of $g(a)-interferon for a long period. More particularly, the present invention relates to an aqueous solution formulation of $g(a)-interferon comprising $g(a)-interferon; a stabilizer; an osmotic pressure regulating agent; antimicrobial preservatives selected from the group consisting of phenol, m-cresol or mixture thereof; and a buffer system. The aqueous solution formulation of the present invention has many advantages because it retains the activity of $g(a)-interferon for a long period, eliminates potential harmfulness to human body by minimizing the amount of the preservatives, and is very stable.
(FR)L'invention concerne une formulation de solution aqueuse capable de retenir durablement l'activité biologique et les propriétés physico-chimiques de l'interféron-$g(a). Plus précisément, l'invention concerne une formulation de solution aqueuse de l'interféron-$g(a) comprenant l'interféron-$g(a); un stabilisant; un agent régulateur de pression osmotique; des conservateurs antimicrobiens choisis dans le groupe constitué de phénol, de m-crésol ou de mélange de ceux-ci; et un système tampon. Ladite formulation de solution aqueuse présente de nombreux avantages car elle retient durablement l'activité de l'interféron-$g(a), élimine la nocivité éventuelle pour le corps humain en réduisant la quantité de conservateurs. Elle est en outre très stable.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)